Special Issue

Topic: Treatment of Pancreatic Cancer
A Special Issue of Journal of Cancer Metastasis and Treatment
ISSN 2454-2857 (Online) 2394-4722 (Print)
Submission deadline: 30 Apr 2022
Guest Editor(s)
Special Issue Introduction
Pancreatic cancer is an increasingly common malignancy that has benefited very little from research advancements and new discoveries, as it remains largely an untreatable disease with a 5-year survival rate lower than 9%. The reasons for this setback are searched in the lack of specific early-stage symptomatology, leading to a late diagnosis and consequently limited option of treatment, as well as resistance to chemo- and radiotherapy and high metastatic potential. Disruption of cell signaling pathways and genetic alterations involving activation of oncogenes and blocking of tumor suppressors are well known to contribute to the start and progression of this tumor. Yet, new understanding and insight, particularly guiding towards new strategies for improved therapies, is eagerly awaited. This Special Issue intends to publish original research, expert opinions, and reviews on basic, translational and clinical studies connected to different aspects of pancreatic cancer cell biology, genomics, precision medicine, medical oncology, radiation therapy, and surgery.
Keywords
Pancreatic Cancer, biology, genomics, precision medicine, radiation therapy
Submission Deadline
30 Apr 2022
Submission Information
For Author Instructions, please refer to https://oaepublish.com/jcmt/author_instructions
For Online Submission, please login at https://oaemesas.com/login?JournalId=jcmt&SpecialIssueId=876
Submission Deadline: 30 Apr 2022
Contacts: Carl Zhou, Assistant Editor, Carl.Zhou@jcmtjournal.com
Published Articles
Open Access Review
Recent advances in detecting premalignant pancreatic cysts
This article belongs to the Special Issue Treatment of Pancreatic Cancer
J Cancer Metastasis Treat 2023;9:11.
Published on: 14 Apr 2023
Open Access Review
Two rare cancers of the exocrine pancreas: to treat or not to treat like ductal adenocarcinoma?
This article belongs to the Special Issue Treatment of Pancreatic Cancer
J Cancer Metastasis Treat 2023;9:5.
Published on: 6 Mar 2023
Open Access Opinion
More efficient clinical trials in pancreatic cancer: develop better treatment options, faster
This article belongs to the Special Issue Treatment of Pancreatic Cancer
J Cancer Metastasis Treat 2022;8:46.
Published on: 18 Oct 2022
Open Access Review
Neoadjuvant treatment of pancreatic ductal adenocarcinoma: present and future
This article belongs to the Special Issue Treatment of Pancreatic Cancer
J Cancer Metastasis Treat 2022;8:38.
Published on: 17 Sep 2022
Open Access Review
A shifting adversary: control of pancreatic cancer transcriptomic subtypes
This article belongs to the Special Issue Treatment of Pancreatic Cancer
J Cancer Metastasis Treat 2022;8:32.
Published on: 21 Aug 2022
Open Access Review
The role of systemic therapy in borderline resectable and locally advanced pancreatic ductal adenocarcinoma
This article belongs to the Special Issue Treatment of Pancreatic Cancer
J Cancer Metastasis Treat 2022;8:30.
Published on: 14 Aug 2022
Open Access Review
Utility of circulating tumor DNA for predicting prognosis in the management of resectable pancreatic cancer
This article belongs to the Special Issue Treatment of Pancreatic Cancer
J Cancer Metastasis Treat 2022;8:29.
Published on: 28 Jul 2022